Malissovas et al., 2016
- Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
Human molecular genetics
25:1528-42
Full text @ Hum. Mol. Genet.
Human Disease | Fish | Environment | Evidence Code |
---|---|---|---|
Charcot-Marie-Tooth disease type 2 | gars1s266/s266 | standard conditions |